ARTG Entry
RILAST
ARTG entry for RILAST (budesonide, formoterol fumarate dihydrate), ARTG 396688 — Product Information, dosage form, registration history. Compiled by…
- Sponsor: AstraZeneca
- Active ingredient: budesonide, formoterol fumarate dihydrate
- Therapeutic area: Respiratory
I cannot write a Brand Dossier for RILAST based on the provided documents.
The documents contain information about two different products:
1. **BUDENOFALK capsules** (budesonide 3 mg) — a registered Australian medicine for Crohn's disease, with comprehensive product information.
2. **RILAST inhalers** — five ARTG registrations for respiratory products (TURBUHALER and RAPIHALER devices containing budesonide/formoterol combinations), with only basic ARTG registration metadata.
The RILAST products are inhalation devices for respiratory use, whereas the detailed product information provided relates exclusively to BUDENOFALK, an oral capsule for gastrointestinal disease.
To write an accurate Brand Dossier for RILAST, I would need: — Product Information document(s) for RILAST TURBUHALER and/or RILAST RAPIHALER — PBS listing information (if applicable) — Regulatory history including PBAC decisions and AusPAR details — Approved indications, dosing, safety warnings, and contraindications specific to the RILAST inhalation products
The ARTG metadata alone does not provide sufficient clinical content to populate the required dossier sections without violating the citation requirement that every factual claim must be supported by the source documents.